According to our latest research, the global liver cancer drugs market size reached USD 2.41 billion in 2024, reflecting a robust expansion driven by rising incidence rates and advancements in therapeutics. The market is projected to grow at a CAGR of 7.9% from 2025 to 2033, culminating in a forecasted market size of approximately USD 4.90 billion by 2033. This sustained growth is primarily attributed to increasing prevalence of liver cancer, growing awareness about early diagnosis, and the emergence of innovative drug therapies that are reshaping the treatment landscape. https://growthmarketreports.com/report/liver-cancer-drugs-market-global-industry-analysis